Insider Trades63 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Sell | BAX | Steven P. Wallace | President, Adv. Surgery | 153 | $18.68 | $11.7B | -22.96% | +43.74% | $2.9K | -0.22% | — | Buy Now |
| Jun 2, 2026 | Sell | BAX | James Teaff | President, CCS | 321 | $18.68 | $11.7B | -22.96% | +43.74% | $6.0K | -1.02% | — | Buy Now |
| Mar 6, 2026 | Sell | BAX | Anita A Zielinski | SVP, CAO and Controller | 1,932 | $17.69 | $11.7B | -22.96% | +43.74% | $34.2K | -4.01% | — | Buy Now |
| Mar 6, 2026 | Sell | BAX | Maria Cecilia Soriano | Group Pres., ITT & Pharma. | 2,848 | $17.69 | $11.7B | -22.96% | +43.74% | $50.4K | -3.66% | — | Buy Now |
| Mar 6, 2026 | Sell | BAX | David S. Rosenbloom | EVP and General Counsel | 6,620 | $17.69 | $11.7B | -22.96% | +43.74% | $117.1K | -4.57% | — | Buy Now |
| Mar 6, 2026 | Sell | BAX | Joel T. Grade | EVP and CFO | 8,153 | $17.69 | $11.7B | -22.96% | +43.74% | $144.2K | -2.91% | — | Buy Now |
| Mar 6, 2026 | Sell | BAX | Reazur Rasul | EVP,Group Pres,Healthcare | 12,674 | $17.69 | $11.7B | -22.96% | +43.74% | $224.2K | -9.17% | — | Buy Now |
| Mar 2, 2026 | Sell | BAX | David S. Rosenbloom | EVP and General Counsel | 1,336 | $19.69 | $11.7B | -22.96% | +43.74% | $26.3K | -0.63% | — | Buy Now |
| Mar 2, 2026 | Sell | BAX | Reazur Rasul | EVP,Group Pres,Healthcare | 1,614 | $19.69 | $11.7B | -22.96% | +43.74% | $31.8K | -1.15% | — | Buy Now |
| Mar 2, 2026 | Sell | BAX | Maria Cecilia Soriano | Group Pres., ITT & Pharma. | 1,852 | $19.69 | $11.7B | -22.96% | +43.74% | $36.5K | -1.35% | — | Buy Now |
| Feb 9, 2026 | Sell | BAX | Maria Cecilia Soriano | Group Pres., ITT & Pharma. | 918 | $21.73 | $11.7B | -22.96% | +43.74% | $19.9K | -1.61% | — | Buy Now |
| Feb 9, 2026 | Sell | BAX | David S. Rosenbloom | EVP and General Counsel | 5,225 | $21.73 | $11.7B | -22.96% | +43.74% | $113.5K | -4.19% | — | Buy Now |
| Feb 9, 2026 | Sell | BAX | Reazur Rasul | EVP,Group Pres,Healthcare | 5,770 | $21.73 | $11.7B | -22.96% | +43.74% | $125.4K | -3.96% | — | Buy Now |
| Feb 9, 2026 | Sell | BAX | Joel T. Grade | EVP and CFO | 9,144 | $21.73 | $11.7B | -22.96% | +43.74% | $198.7K | -3.72% | — | Buy Now |
| Dec 12, 2025 | Sell | BAX | Jeanne K Mason | EVP, Chief HR Officer | 650 | $19.15 | $11.7B | -22.96% | +43.74% | $12.4K | -0.32% | — | Buy Now |
| Dec 1, 2025 | Sell | BAX | Joel T. Grade | EVP and CFO | 8,288 | $19.08 | $11.7B | -22.96% | +43.74% | $158.1K | -3.71% | — | Buy Now |
| Sep 2, 2025 | Sell | BAX | James W Borzi | EVP,Chief Supply Chain Officer | 1,848 | $24.17 | $11.7B | -22.96% | +43.74% | $44.7K | -2.50% | — | Buy Now |
| Sep 2, 2025 | Sell | BAX | Alok Sonig | EVP,Group President,Pharma | 3,191 | $24.17 | $11.7B | -22.96% | +43.74% | $77.1K | -2.43% | — | Buy Now |
| Jun 2, 2025 | Sell | BAX | David S. Rosenbloom | EVP and General Counsel | 16,548 | $29.55 | $11.7B | -22.96% | +43.74% | $489.0K | -13.47% | — | Buy Now |
| Mar 6, 2025 | Sell | BAX | James W Borzi | EVP,Chief Supply Chain Officer | 3,262 | $35.44 | $11.7B | -22.96% | +43.74% | $115.6K | -3.27% | — | Buy Now |
| Mar 6, 2025 | Sell | BAX | Joel T. Grade | EVP and CFO | 4,306 | $35.44 | $11.7B | -22.96% | +43.74% | $152.6K | -2.25% | — | Buy Now |
| Mar 6, 2025 | Sell | BAX | Jeanne K Mason | EVP, Chief HR Officer | 4,375 | $35.44 | $11.7B | -22.96% | +43.74% | $155.1K | -1.82% | — | Buy Now |
| Mar 6, 2025 | Sell | BAX | David S. Rosenbloom | EVP and General Counsel | 4,922 | $35.44 | $11.7B | -22.96% | +43.74% | $174.4K | -2.92% | — | Buy Now |
| Mar 6, 2025 | Sell | BAX | Reazur Rasul | EVP,Group Pres,Healthcare | 9,341 | $35.44 | $11.7B | -22.96% | +43.74% | $331.0K | -4.79% | — | Buy Now |
| Mar 6, 2025 | Sell | BAX | Alok Sonig | EVP,Group President,Pharma | 10,839 | $35.44 | $11.7B | -22.96% | +43.74% | $384.1K | -5.14% | — | Buy Now |
| Mar 6, 2025 | Sell | BAX | Heather Knight | EVP, Chief Operating Officer | 13,634 | $35.44 | $11.7B | -22.96% | +43.74% | $483.2K | -4.97% | — | Buy Now |
| Mar 3, 2025 | Sell | BAX | David S. Rosenbloom | EVP and General Counsel | 1,312 | $34.86 | $11.7B | -22.96% | +43.74% | $45.7K | -1.18% | — | Buy Now |
| Mar 3, 2025 | Sell | BAX | James W Borzi | EVP,Chief Suppy Chain Officer | 1,339 | $34.86 | $11.7B | -22.96% | +43.74% | $46.7K | -1.98% | — | Buy Now |
| Mar 3, 2025 | Sell | BAX | Jeanne K Mason | EVP, Chief HR Officer | 1,479 | $34.86 | $11.7B | -22.96% | +43.74% | $51.6K | -0.78% | — | Buy Now |
| Mar 3, 2025 | Sell | BAX | Alok Sonig | EVP,Group President,Pharma | 1,936 | $34.86 | $11.7B | -22.96% | +43.74% | $67.5K | -1.71% | — | Buy Now |
| Mar 3, 2025 | Sell | BAX | Reazur Rasul | EVP,Group Pres,Healthcare | 1,987 | $34.86 | $11.7B | -22.96% | +43.74% | $69.3K | -1.81% | — | Buy Now |
| Mar 3, 2025 | Sell | BAX | Heather Knight | EVP, Chief Operating Officer | 3,344 | $34.86 | $11.7B | -22.96% | +43.74% | $116.6K | -2.11% | — | Buy Now |
| Jan 31, 2025 | Sell | BAX | Christopher A. Toth | EVP, Group Pres, Kidney Care | 25,372 | $32.56 | $11.7B | -22.96% | +43.74% | $826.1K | -19.43% | — | Buy Now |
| Dec 31, 2024 | Sell | BAX | Christopher A. Toth | EVP,Group Pres, Kidney Care | 32,610 | $29.16 | $11.7B | -22.96% | +43.74% | $950.9K | -15.06% | — | Buy Now |
| Dec 13, 2024 | Sell | BAX | Jose E Almeida | Chairman, CEO, President | 5,966 | $30.32 | $11.7B | -22.96% | +43.74% | $180.9K | -2.39% | — | Buy Now |
| Dec 2, 2024 | Sell | BAX | Reazur Rasul | EVP,Group Pres,Healthcare | 2,032 | $33.55 | $11.7B | -22.96% | +43.74% | $68.2K | -1.83% | — | Buy Now |
| Dec 2, 2024 | Sell | BAX | Heather Knight | EVP, Group Pres, Med Products | 6,041 | $33.55 | $11.7B | -22.96% | +43.74% | $202.7K | -3.69% | — | Buy Now |
| Dec 2, 2024 | Sell | BAX | Joel T. Grade | EVP and CFO | 6,612 | $33.55 | $11.7B | -22.96% | +43.74% | $221.8K | -6.67% | — | Buy Now |
| Sep 3, 2024 | Sell | BAX | James W Borzi | EVP,Chief Supply Chain Officer | 1,685 | $37.85 | $11.7B | -22.96% | +43.74% | $63.8K | -2.46% | — | Buy Now |
| Sep 3, 2024 | Sell | BAX | Alok Sonig | EVP,Group President, Pharma | 3,054 | $37.85 | $11.7B | -22.96% | +43.74% | $115.6K | -2.66% | — | Buy Now |
| Jun 3, 2024 | Sell | BAX | David S. Rosenbloom | EVP and General Counsel | 784 | $34.08 | $11.7B | -22.96% | +43.74% | $26.7K | -0.72% | — | Buy Now |
| Jun 3, 2024 | Sell | BAX | Christopher A. Toth | EVP,Group Pres, Kidney Care | 15,202 | $34.08 | $11.7B | -22.96% | +43.74% | $518.1K | -6.65% | — | Buy Now |
| Mar 4, 2024 | Sell | BAX | James W Borzi | EVP,Chief Supply Chain Officer | 420 | $42.50 | $11.7B | -22.96% | +43.74% | $17.9K | -1.21% | — | Buy Now |
| Mar 4, 2024 | Sell | BAX | Jeanne K Mason | EVP, Chief HR Officer | 475 | $42.50 | $11.7B | -22.96% | +43.74% | $20.2K | -0.34% | — | Buy Now |
| Mar 4, 2024 | Sell | BAX | Reazur Rasul | EVP, Group Pres, Healthcare | 522 | $42.50 | $11.7B | -22.96% | +43.74% | $22.2K | -1.98% | — | Buy Now |
| Mar 4, 2024 | Sell | BAX | Brian Stevens | SVP, CAO & Controller | 545 | $42.50 | $11.7B | -22.96% | +43.74% | $23.2K | -1.01% | — | Buy Now |
| Mar 4, 2024 | Sell | BAX | Heather Knight | EVP,Group Pres, Med Products | 1,320 | $42.50 | $11.7B | -22.96% | +43.74% | $56.1K | -2.42% | — | Buy Now |
| Mar 4, 2024 | Sell | BAX | Jose E Almeida | Chairman, CEO, President | 4,779 | $42.50 | $11.7B | -22.96% | +43.74% | $203.1K | -4.47% | — | Buy Now |
| Mar 1, 2024 | Sell | BAX | Brian Stevens | SVP, CAO & Controller | 673 | $41.01 | $11.7B | -22.96% | +43.74% | $27.6K | -1.24% | — | Buy Now |
| Mar 1, 2024 | Sell | BAX | James W Borzi | EVP, Chief Supply Chain Offcr | 852 | $41.01 | $11.7B | -22.96% | +43.74% | $34.9K | -2.39% | — | Buy Now |
| Mar 1, 2024 | Sell | BAX | David S. Rosenbloom | EVP and General Counsel | 1,416 | $41.01 | $11.7B | -22.96% | +43.74% | $58.1K | -2.49% | — | Buy Now |
| Mar 1, 2024 | Sell | BAX | Reazur Rasul | EVP, Group Pres, Healthcare | 1,538 | $41.01 | $11.7B | -22.96% | +43.74% | $63.1K | -5.51% | — | Buy Now |
| Mar 1, 2024 | Sell | BAX | Alok Sonig | EVP, Group President, Pharma | 1,832 | $41.01 | $11.7B | -22.96% | +43.74% | $75.1K | -5.74% | — | Buy Now |
| Mar 1, 2024 | Sell | BAX | Heather Knight | EVP, Group Pres, Med Products | 2,154 | $41.01 | $11.7B | -22.96% | +43.74% | $88.3K | -3.80% | — | Buy Now |
| Mar 1, 2024 | Sell | BAX | Jose E Almeida | Chairman, CEO, President | 9,701 | $41.01 | $11.7B | -22.96% | +43.74% | $397.8K | -8.33% | — | Buy Now |
| Mar 1, 2024 | Sell | BAX | Jeanne K Mason | EVP, Chief HR Officer | 129,939 | $38.91 | $11.7B | -22.96% | +43.74% | $5.1M | -0.20% | 10b5-1 | Buy Now |
| Feb 12, 2024 | Sell | BAX | Reaz Rasul | EVP, Group Pres, Healthcare | 248 | $40.31 | $11.7B | -22.96% | +43.74% | $10.0K | -0.88% | — | Buy Now |
| Feb 12, 2024 | Sell | BAX | Brian Stevens | SVP, CAO & Controller | 284 | $40.31 | $11.7B | -22.96% | +43.74% | $11.4K | -0.52% | — | Buy Now |
| Feb 12, 2024 | Sell | BAX | Heather Knight | EVP, Group Pres, Med Products | 356 | $40.31 | $11.7B | -22.96% | +43.74% | $14.4K | -0.63% | — | Buy Now |
| Feb 12, 2024 | Sell | BAX | James W Borzi | EVP, Chief Supply Chain Office | 1,311 | $40.31 | $11.7B | -22.96% | +43.74% | $52.8K | -3.55% | — | Buy Now |
| Feb 12, 2024 | Sell | BAX | Jeanne K Mason | EVP, Chief HR Officer | 1,463 | $40.31 | $11.7B | -22.96% | +43.74% | $59.0K | -1.02% | — | Buy Now |
| Feb 12, 2024 | Sell | BAX | Jose E Almeida | Chairman, CEO, President | 10,863 | $40.31 | $11.7B | -22.96% | +43.74% | $437.9K | -8.53% | — | Buy Now |
| Sep 1, 2023 | Sell | BAX | Alok Sonig | EVP, Group President, Pharm | 2,059 | $40.60 | $11.7B | -22.96% | +43.74% | $83.6K | -6.13% | — | Buy Now |